More on PRN
Data
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $247.56 |
|
|||
| Open | $247.56 | ||||
| 52 Wk High | $49.94 | ||||
| 52 Wk Low | $38.52 | ||||
| Day High | $247.56 | ||||
| Day Low | $247.56 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 422 | ||||
- Telix partners with EDAP and Profound on prostate imaging tech
- Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
- Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026
- Profound Medical Reports Strong First Quarter 2026 Financial Results
- Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow
- Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference
Entities mentioned with PRN
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Cowen & Co | View Related Stories »
- Raymond James | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Jefferies & Co | View Related Stories »
- CIBC | View Related Stories »
- Show More...
